A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer (vol 350, pg 1081, 2004)

被引：0
|
作者：
Coombes, RC
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2461 / 2461
页数：1
相关论文
共 50 条
  • [21] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    Machin, D
    Andersen, KW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 659 - 659
  • [22] Neuropsychological sequelae of tamoxifen and exemestane after AC-chemotherapy in postmenopausal women with early breast cancer
    Schilder, C. M.
    Eggens, P. C.
    Boogerd, W.
    van Dam, F. S.
    Schagen, S. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer (vol 350, pg 1200, 2004)
    Neoptolemos, JP
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (07) : 726 - 726
  • [24] Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial
    Kaufmann, M
    Bajetta, E
    Dirix, LY
    Fein, LE
    Jones, SE
    Zilembo, N
    Dugardyn, JC
    Nasurdi, C
    Mennel, RG
    Cervek, J
    Fowst, C
    Polli, A
    di Salle, E
    Arkhipov, A
    Piscitelli, G
    Miller, LL
    Massimini, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1399 - 1411
  • [25] Randomized phase III trial of exemestane or tamoxifen in first-line hormonal treatment of postmenopausal women with metastatic breast cancer.
    Chernozemsky, I
    Kalinov, K.
    Tzekov, H.
    Racheva, M.
    Hristova, S.
    Tomova, A.
    Koynova, T.
    Taskova, V
    Boideva, L.
    Eniu, A.
    Krasteva, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S119 - S119
  • [26] Exemestane for Breast-Cancer Prevention in Postmenopausal Women (vol 364, pg 2381, 2011)
    Goss, P. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14) : 1361 - 1361
  • [27] The effect of tamoxifen or exemestane on bone mineral density after 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
    Asmar, L.
    Negron, A.
    Stokoe, C.
    Sborov, M.
    Braun, M.
    Ethirajan, S.
    Patel, M.
    Davis, J.
    Ilegbodu, D.
    Jones, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S115 - S115
  • [28] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer - Response
    Rutqvist, LE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) : 659 - 660
  • [29] Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
    Mieog, J. Sven D.
    Morden, James P.
    Bliss, Judith M.
    Coombes, R. Charles
    van de Velde, Cornelis J. H.
    LANCET ONCOLOGY, 2012, 13 (04) : 420 - 432
  • [30] Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)-a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen
    Bertelli, G.
    Hall, E.
    Ireland, E.
    Snowdon, C. F.
    Jassem, J.
    Drosik, K.
    Karnicka-Mlodkowska, H.
    Coombes, R. C.
    Bliss, J. M.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 498 - 505
12345